Beta adrenergic receptor compositions and methods of use thereof

Abstract

Compositions and methods for treatment of one or more metabolic disorders in a subject are provided. Disclosures herein are directed to compositions comprising a beta-adrenergic receptor (ADRB1) antagonist and a beta-3 adrenergic receptor (ADRB3) agonist and methods of using such compositions for …